Eversept Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-148,688
| Closed | -$11.6M | – | 60 |
|
|
2024
Q4 | $11.6M | Buy |
+148,688
| New | +$11.6M | 1.03% | 19 |
|
|
2022
Q3 | – | Sell |
-14,468
| Closed | -$1.08M | – | 66 |
|
|
2022
Q2 | $1.08M | Sell |
14,468
-99,148
| -87% | -$7.39M | 0.08% | 54 |
|
|
2022
Q1 | $14.5M | Buy |
113,616
+88,012
| +344% | +$11.3M | 1.12% | 23 |
|
|
2021
Q4 | $3.44M | Hold |
25,604
| – | – | 0.22% | 58 |
|
|
2021
Q3 | $3.5M | Sell |
25,604
-12,496
| -33% | -$1.71M | 0.24% | 49 |
|
|
2021
Q2 | $4.07M | Sell |
38,100
-36,864
| -49% | -$3.94M | 0.27% | 41 |
|
|
2021
Q1 | $6.74M | Buy |
74,964
+65,072
| +658% | +$5.85M | 0.51% | 39 |
|
|
2020
Q4 | $914K | Buy |
+9,892
| New | +$914K | 0.11% | 49 |
|
|
2020
Q3 | – | Sell |
-26,680
| Closed | -$2.7M | – | 56 |
|
|
2020
Q2 | $2.7M | Sell |
26,680
-51,468
| -66% | -$5.22M | 0.37% | 37 |
|
|
2020
Q1 | $5.26M | Buy |
78,148
+29,948
| +62% | +$2.02M | 1.31% | 17 |
|
|
2019
Q4 | $2.64M | Sell |
48,200
-130,000
| -73% | -$7.11M | 0.47% | 38 |
|
|
2019
Q3 | $6.65M | Buy |
+178,200
| New | +$6.65M | 2.06% | 14 |
|